Photo by nci from unsplash
R. Gniadecki has received speaker’s honorarium from Mallinckrodt, Janssen, AbbVie, Novartis, and Leo Pharma, and is on the advisory board for Mallinckrodt, Janssen, Amgen, AbbVie, Eli Lily, Sanofi, Novartis, and… Click to show full abstract
R. Gniadecki has received speaker’s honorarium from Mallinckrodt, Janssen, AbbVie, Novartis, and Leo Pharma, and is on the advisory board for Mallinckrodt, Janssen, Amgen, AbbVie, Eli Lily, Sanofi, Novartis, and Leo Pharma. R. Gniadecki is an investigator in clinical trials for Janssen, Celgene, AbbVie, and Leo Pharma. The remaining authors have indicated no significant interest with commercial supporters.
Keywords:
leo pharma;
oral intraincisional;
surgery commentary;
intraincisional antibiotic;
antibiotic prophylaxis;
commentary oral
Journal Title: Dermatologic Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Dermatologic Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!